These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10489722)

  • 1. Evaluation of the completeness of reporting of invasive meningococcal disease.
    Rivest P; Sagot B; Bédard L
    Can J Public Health; 1999; 90(4):250-2. PubMed ID: 10489722
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive meningococcal disease in Austria 2002: assessment of completeness of notification by comparison of two independent data sources.
    Berghold C; Berghold A; Fülöp G; Heuberger S; Strauss R; Zenz W
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):31-5. PubMed ID: 16489523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive meningococcal disease: completeness and timeliness of reporting of confirmed cases in Thames Valley, 2006-2007.
    Paranthaman K; Kent L; McCarthy N; Gray SJ
    Public Health; 2009 Dec; 123(12):805-8. PubMed ID: 19958917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of surveillance for meningococcal disease in New York State, 1991.
    Ackman DM; Birkhead G; Flynn M
    Am J Epidemiol; 1996 Jul; 144(1):78-82. PubMed ID: 8659488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completeness and timeliness of reporting of meningococcal disease--Maine, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(7):169-72. PubMed ID: 19247263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002.
    Howitz MF; Samuelsson S; Mølbak K
    Epidemiol Infect; 2008 Aug; 136(8):1088-95. PubMed ID: 17892628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective assessment of the completeness and timeliness of meningococcal disease notifications in the Republic of Ireland over a 16-year period, 1999-2015.
    O'Lorcain P; Bennett DE; Morgan SL; Cunney RJ; Cotter SM; Cafferkey MT; O'Flanagan DM
    Public Health; 2018 Mar; 156():44-51. PubMed ID: 29408188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicable diseases surveillance. Highlights for 2nd quarter, 2002.
    Commun Dis Intell Q Rep; 2002; 26(3):472-95. PubMed ID: 12416716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease and the law: does non-notification really happen?
    Robinson P
    Commun Dis Intell; 1999 Apr; 23(4):97-101. PubMed ID: 10736954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses.
    de Greeff SC; Spanjaard L; Dankert J; Hoebe CJ; Nagelkerke N; de Melker HE
    Eur J Epidemiol; 2006; 21(4):315-21. PubMed ID: 16685583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of disease registries for compulsory declaration of meningococcal infections using the capture-recapture method].
    Pañella Noguera H; Orcau Palau A; Muñoz P
    Rev Esp Salud Publica; 1998; 72(5):455-7. PubMed ID: 9951343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the surveillance of invasive meningococcal disease in Tunisia: capture-recapture method].
    Bettaieb J; Bellali H; Ben Alaya N; Mrabet A; Kouni Chahed M
    Sante Publique; 2013; 25(5):609-15. PubMed ID: 24418423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A European survey on public health policies for managing cases of meningococcal disease and their contacts.
    Hoek M; Hanquet G; Heuberger S; Stefanoff P; Zucs P; Ramsay M; Stuart J;
    Euro Surveill; 2008 Mar; 13(10):. PubMed ID: 18445439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New communicable disease notification system launched in Turkey.
    Bayazit Y; Buyurgan V; Tumay S
    Euro Surveill; 2005 Apr; 10(4):E050421.5. PubMed ID: 16766815
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced surveillance of meningococcal disease.
    Commun Dis Rep CDR Wkly; 1998 Jan; 8(1):1. PubMed ID: 9476416
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges to the surveillance of meningococcal disease in an era of declining incidence in montréal, Québec.
    Ratnayake R; Allard R
    Can J Public Health; 2013 May; 104(4):e335-9. PubMed ID: 24044476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential effects of electronic laboratory reporting on improving timeliness of infectious disease notification--Florida, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(49):1325-8. PubMed ID: 19078921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the obstacles to consistent intravenous catheter-related infection reporting by home health providers.
    Hanchett M
    J Intraven Nurs; 1999; 22(6):320-4. PubMed ID: 10865599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004-2016.
    Brandwagt DAH; van der Ende A; Ruijs WLM; de Melker HE; Knol MJ
    BMC Infect Dis; 2019 Oct; 19(1):860. PubMed ID: 31623567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.